ResearcherQiqihar Medical UniversityNo recent work listed

Yingbo Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0427-5453; OpenAlex author ID A5100707181. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2019: 1 paper

Papers 1

Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway. Co-author DOI 10.3892/ol.2019.10790 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lili Zhong · 1 shared paper, 2019 · strength 0.11
- Paper Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway. DOI 10.3892/ol.2019.10790 ↗
Shuliang Wu · 1 shared paper, 2019 · strength 0.11
- Paper Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway. DOI 10.3892/ol.2019.10790 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.